Systemax (SYX) Holder Goodhaven Capital Management Trimmed Holding by $3.66 Million as Market Valuation Declined; Bruker (BRKR) Holder Thompson Rubinstein Investment Management Has Decreased Position by $958,290

May 3, 2018 - By Ellis Scott

Bruker Corporation (NASDAQ:BRKR) Logo

Goodhaven Capital Management Llc decreased its stake in Systemax Inc (SYX) by 27.37% based on its latest 2017Q4 regulatory filing with the SEC. Goodhaven Capital Management Llc sold 110,942 shares as the company’s stock declined 3.60% with the market. The institutional investor held 294,330 shares of the catalog and specialty distribution company at the end of 2017Q4, valued at $9.79 million, down from 405,272 at the end of the previous reported quarter. Goodhaven Capital Management Llc who had been investing in Systemax Inc for a number of months, seems to be less bullish one the $1.13 billion market cap company. The stock decreased 1.11% or $0.34 during the last trading session, reaching $30.33. About 40,589 shares traded. Systemax Inc. (NYSE:SYX) has risen 207.79% since May 3, 2017 and is uptrending. It has outperformed by 196.24% the S&P500.




Thompson Rubinstein Investment Management Inc decreased its stake in Bruker Corporation (BRKR) by 17.33% based on its latest 2017Q4 regulatory filing with the SEC. Thompson Rubinstein Investment Management Inc sold 28,185 shares as the company’s stock declined 13.70% with the market. The institutional investor held 134,447 shares of the laboratory analytical instruments company at the end of 2017Q4, valued at $4.61 million, down from 162,632 at the end of the previous reported quarter. Thompson Rubinstein Investment Management Inc who had been investing in Bruker Corporation for a number of months, seems to be less bullish one the $4.62B market cap company. The stock increased 0.34% or $0.1 during the last trading session, reaching $29.59. About 1.24M shares traded or 106.88% up from the average. Bruker Corporation (NASDAQ:BRKR) has risen 29.39% since May 3, 2017 and is uptrending. It has outperformed by 17.84% the S&P500.

Investors sentiment increased to 1.16 in 2017 Q4. Its up 0.25, from 0.91 in 2017Q3. It improved, as 11 investors sold BRKR shares while 75 reduced holdings. 45 funds opened positions while 55 raised stakes. 97.01 million shares or 2.08% less from 99.08 million shares in 2017Q3 were reported. First Quadrant Lp Ca has invested 0.54% in Bruker Corporation (NASDAQ:BRKR). Denver Inv Advisors Ltd Llc reported 7,165 shares. Menta Capital Limited Liability reported 8,300 shares. Blb&B Advsrs Limited invested 0.1% in Bruker Corporation (NASDAQ:BRKR). Horizon Kinetics Lc holds 11,690 shares or 0.01% of its portfolio. Dimensional Fund Advisors LP has 940,713 shares. Moreover, Meeder Asset Management has 0% invested in Bruker Corporation (NASDAQ:BRKR). Royal Savings Bank Of Canada owns 49,512 shares for 0% of their portfolio. Alliancebernstein LP reported 0.05% of its portfolio in Bruker Corporation (NASDAQ:BRKR). Panagora Asset Management reported 500,903 shares or 0.06% of all its holdings. Gabelli Funds Lc owns 18,000 shares or 0% of their US portfolio. Barclays Public Limited Co owns 152,331 shares. Vanguard Grp has 0.01% invested in Bruker Corporation (NASDAQ:BRKR). Citadel Advsr Ltd Liability has invested 0% in Bruker Corporation (NASDAQ:BRKR). Invesco Ltd holds 0% or 100,557 shares.

Among 16 analysts covering Bruker (NASDAQ:BRKR), 4 have Buy rating, 2 Sell and 10 Hold. Therefore 25% are positive. Bruker had 47 analyst reports since August 20, 2015 according to SRatingsIntel. The rating was initiated by Deutsche Bank on Thursday, January 7 with “Hold”. The stock of Bruker Corporation (NASDAQ:BRKR) has “Equal-Weight” rating given on Thursday, December 14 by Morgan Stanley. Barclays Capital downgraded it to “Equal Weight” rating and $22 target in Wednesday, January 4 report. Morgan Stanley maintained the stock with “Equal-Weight” rating in Friday, February 9 report. The company was initiated on Tuesday, September 15 by Morgan Stanley. The stock has “Buy” rating by Jefferies on Friday, August 4. The rating was reinitiated by Leerink Swann with “Market Perform” on Thursday, November 10. The firm has “Buy” rating by Jefferies given on Thursday, November 9. As per Friday, November 3, the company rating was maintained by Citigroup. On Thursday, July 13 the stock rating was maintained by Jefferies with “Buy”.

Thompson Rubinstein Investment Management Inc, which manages about $259.90M and $303.75 million US Long portfolio, upped its stake in Novartis Ag Spon Adr (NYSE:NVS) by 5,795 shares to 74,866 shares, valued at $6.29 million in 2017Q4, according to the filing.

Investors sentiment decreased to 1.36 in 2017 Q4. Its down 1.21, from 2.57 in 2017Q3. It is negative, as 8 investors sold SYX shares while 31 reduced holdings. 23 funds opened positions while 30 raised stakes. 10.21 million shares or 3.06% more from 9.90 million shares in 2017Q3 were reported. Jpmorgan Chase & Com owns 3,086 shares. California Pub Employees Retirement Systems accumulated 37,496 shares. Advisory Net Limited Liability holds 1 shares. 100,919 are held by Ingalls & Snyder Limited Liability Corp. Moreover, Renaissance Technology Ltd has 0% invested in Systemax Inc. (NYSE:SYX) for 129,800 shares. Metropolitan Life Insurance has invested 0% in Systemax Inc. (NYSE:SYX). Bnp Paribas Arbitrage Sa owns 2,474 shares. Prudential Financial invested in 49,431 shares or 0% of the stock. Sei Investments Company holds 0% in Systemax Inc. (NYSE:SYX) or 1,932 shares. Goldman Sachs reported 11,853 shares. Price T Rowe Associates Md invested in 0% or 6,572 shares. Fny Managed Accounts holds 100 shares or 0% of its portfolio. Atlantic Tru Group Inc Llc invested 0% of its portfolio in Systemax Inc. (NYSE:SYX). Deutsche National Bank Ag has invested 0% of its portfolio in Systemax Inc. (NYSE:SYX). King Luther Cap Mngmt reported 0.27% of its portfolio in Systemax Inc. (NYSE:SYX).

Systemax Inc. (NYSE:SYX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts